Circulating ketone bodies in patients with acute heart failure treated with the SGLT2 inhibitor empagliflozin

Back

HFA Premium Access

Circulating ketone bodies in patients with acute heart failure treated with the SGLT2 inhibitor empagliflozin

Session: Acute heartfailure from bench to bedside

Topic: Pharmacotherapy

Speaker: Ms S. Voorrips (Groningen, NL)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Ms Suzanne Nathalie Voorrips

University Medical Centre Groningen, Groningen (Netherlands (The))

0 follower

5 more presentations in this session

Coronary microvascular function in takotsubo syndrome

Speaker: Doctor C. Ekenback (Stockholm, SE)

Is heart failure associated with a worse prognosis than cancer? Five-year survival following hospitalization with heart failure.

Speaker: Professor L. Fauchier (Tours, FR)

Distinct comorbidity clusters in patients with acute heart failure: data from RELAX-AHF-2

Speaker: Miss K. Arevalo Gomez (Groningen, NL)

Hemodynamic impact of graded lower body negative pressure on left ventricular diastolic properties: a pressure volume study.

Speaker: Mr L. Berboth (Berlin, DE)

Phenotyping heart failure with a supranormal ejection fraction

Speaker: Mr B. Van Essen (Groningen, NL)

Access the full session

Acute heartfailure from bench to bedside

Speakers: Ms S. Voorrips, Doctor C. Ekenback, Professor L. Fauchier, Miss K. Arevalo Gomez, Mr L. Berboth...

Access

Video

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources